The François Jacob Institute of Biology brings together five departments and three services
The last two years in scientific news
Find here all the institutional news about the François Jacob Institute of Biology.
The FRM has just selected eight research projects in its call for projects on the fundamental mechanisms of Alzheimer's disease. A financial contribution of up to 600,000 euros has been allocated to fund the salaries, equipment and operating costs for each project for a period of 2 to 3 years. Among the funded projects, a project led by SEPIA (CEA-Jacob), Genoscope (CEA-Jacob) and ENS-Saclay, focuses on the use of cerebral organoids or 'mini-brains' as a model for the study of Alzheimer's disease.
On November 17, 2020, the Life Sciences invite you to their second edition of Meet My Platform | Paris-Saclay University, co-organized with Genopole. Come and discover the potential of technology platforms at Paris-Saclay University. 113 academic platforms and 20 industrial sponsors meet in a dedicated area. Among the speakers of the day, Jean-François Deleuze will present the Centre de Référence d'Innovation et d'Expertise (CRefIX) that he manages, and how this structure allows the development of sequencing protocols for the medicine of the future.
A better understanding of COVID-19 and its spread is essential in order to detect the disease, treat and protect patients. This is why on 30 January 2020, the European Commission launched a request for expressions of interest entitled 'SC1-PHE-CORONAVIRUS-2020: Advancing knowledge for the clinical and public health response to the [COVID-19] epidemic' with a budget of €47.5 million. 17 research projects were shortlisted for funding following evaluation.
With the support of the Ministry of Solidarity and Health and the Ministry of Higher Education, Research and Innovation, 20 scientific initiatives were selected by REACTing's scientific board and presented at a press conference on 11 March. Among them, IDMIT is piloting a fundamental research project on the evolution of Covid-19 in a specific pre-clinical study model.
To develop new treatments for tuberculosis, the world's leading cause of death from infectious diseases, the European Union and the European Federation of Pharmaceutical Industries and Associations are launching the ERA4TB (European Regimen Accelerator for Tuberculosis) consortium combining academic and private research, of which the IDMIT department is a partner
CEA is a French government-funded technological research organisation in four main areas: low-carbon energies, defense and security, information technologies and health technologies. A prominent player in the European Research Area, it is involved in setting up collaborative projects with many partners around the world.